Diffuse systemic-pulmonary anastomoses and chronic hypoxemia may result in increase in ventricular work in bronchiectasis. We aimed to assess right ventricular (RV) and left ventricular (LV) functions in patients with bronchiectasis by using tissue Doppler-derived myocardial performance index (MPI), which is a novel and more sensitive parameter than conventional ventricular function parameters.
Summary Diffuse systemic-pulmonary anastomoses and chronic hypoxemia may result in increase in ventricular work in bronchiectasis. We aimed to assess right ventricular (RV) and left ventricular (LV) functions in patients with bronchiectasis by using tissue Doppler-derived myocardial performance index (MPI), which is a novel and more sensitive parameter than conventional ventricular function parameters.
To assess the possibility of RV and LV dysfunctions occurring in bronchiectasis, we studied 25 patients with bronchiectasis, and compared them with 22 age-and gender-matched control subjects. MPI, which is a combined index of both systolic and diastolic ventricular function, was calculated for both ventricles.
RV and LV MPIs were also significantly different in patients and the controls. RV MPI was associated with the number of involved lobe, arterial blood oxygen pressure, and acceleration time/ejection time of pulmonary flow. LV MPI was not related to any clinical parameter, but it was correlated only with RV MPI.
Ventricular functions are impaired in bronchiectasis. The impairment of RV function is related to involved lung lobe number, arterial oxygen pressure, and acceleration time/ejection time of pulmonary flow. LV dysfunction was correlated only with RV function. & 2006 Elsevier Ltd. All rights reserved.
Introductions
Right ventricular (RV) and left ventricular (LV) dysfunctions in patients with cystic fibrosis (CF) 1, 2 and those with chronic obstructive pulmonary disease (COPD) have been described by previous investigators. [3] [4] [5] [6] Hypoxemia is an important factor that is known to affect RV function in these diseases. 7, 8 Pulmonary hypertension also has a major effect on RV function and has been shown to be associated with increased mortality in patients with CF 8 and COPD. [3] [4] [5] These previous studies suggest that alterations in RV function are a consequence of the combination of long-standing hypoxia and increased pulmonary vascular resistance. Also, bronchiectasis can have important hemodynamic consequences because of proliferation of the bronchial circulation in its vicinity. Moreover, pulmonary dysfunction may develop in the patients. However, there is not always a direct correlation between the type of anatomic shunt (cylindric, etc.) and pulmonary dysfunction measured. Reduced regional ventilation, a lesser degree of reduction in perfusion, and decreased ventilation-perfusion ratios are observed in areas of bronchiectatic involvement. 9, 10 Although both decreased oxygen saturation 11, 12 and increased pulmonary vascular resistance have been shown in bronchiectasis, 11 there is not a study that assessed ventricular functions in detail.
There are several methods used in assessing ventricular function. Echocardiographic methods are commonly used, easy to application, noninvasive and inexpensive. Doppler-derived myocardial performance index (MPI) is a novel echocardiographic parameter, which has combined both systolic and diastolic functions, in assessing ventricular function. 13, 14 Furthermore, it is shown to be more sensitive than conventional echocardiographic parameters. [15] [16] [17] Also, determination of MPI derived by Doppler requires measurement of only two simple intervals on cardiac cycle.
In this study, we aimed to assess RV and LV functions in patients with bronchiectasis by conventional methods and tissue Doppler-derived MPI.
Methods

Patient population
The target population for this study comprised consecutive 25 patients with bronchiectasis. The age range for the patients was between 15 and 62 years. Of the 25 patients recruited into this study, none of them had clinical evidence of overt rightsided heart failure. In addition, 22 healthy control subjects were recruited. None of the control subjects had any clinical evidence of cardiac, pulmonary or the other system's disease. All individuals gave written and informed consent. The study protocol was approved by the local Ethic Committee.
Patients were characterized as having bronchiectasis, based on a history and physical examination findings consistent with the disease and a highresolution computed tomographic scan of the chest. 18 The patients were in steady state (defined by no significant changes in respiratory symptoms or signs for at least 3 weeks). None of the patients underwent surgery concerning bronchiectasis or other thoracic disease. Patients with a history or findings according to spirometry data and physical examination of COPD, asthma, sleep apneas, other concomitant lung disease, cardiovascular disorders, obesity, and other serious acute or chronic disease were excluded. CF was excluded on the basis of a sweat test. Pulmonary function tests were measured between 10 and 11 am using standard protocols as recommended by the American Thoracic Society, with a pulmonary function analyzer (ZAN 530 Body pletismography, Germany). 19 Forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) (in percent predicted) were obtained. Arterial blood gas assessment was done to measure partial pressure of arterial oxygen blood and partial pressure of carbon dioxide blood by means of radial artery puncture breathing room air.
Echocardiograms
In all individuals, echocardiographic examinations were performed using a machine (Aloka Prosound SSD 5000, Tokyo, Japan) with a 3-MHz transducer. All the echocardiographic measurements were performed by two experienced cardiologists, unaware of the patients' clinical characteristics. All measurements were calculated from an average of three consecutive cardiac cycles. Correction of the pulsed wave Doppler tissue-derived time intervals for different heart rates was performed by dividing the values by the square root of the cardiac cycle length (i.e., R-R interval). 20 a-RV functions RV end-systolic and end-diastolic diameters and areas, RV fractional shortening, RV area change, and tricuspid annular plane systolic excursion (TAPSE) 21 were obtained.
From Doppler recordings of trans-tricuspid flow, the following variables were measured: Et, At, Et/ At ratio, and deceleration time of Et. 22 The RV systolic pressure or pulmonary artery systolic pressure (PASP) was measured by adding the assumed right atrial pressure of 10 mmHg to this gradient (fixed value method). 23 In addition, pulmonary artery flow acceleration time divided by ejection time of pulmonary artery blood flow (AT/ET) was obtained. 24 Pulsed wave Doppler tissue echocardiographic recordings were obtained from the lateral corner of the tricuspid annulus. Then, the RV MPI (RVMPI) was calculated as ða À bÞ=b. ''a'' was equal to the sum ARTICLE IN PRESS of isovolumic contraction time (ICTr) and ejection time (ETr) and isovolumic relaxation time (IRTr), and ''b'' was measured as the duration of the systolic annular velocity (ETr)] ( Fig. 1 ). 14 
b-LV functions
M-mode echocardiographic measurements were obtained on the basis of the standards of the American Society of Echocardiography. 25 LV systolic and diastolic dimensions, septal thickness, posterior wall thickness, and left atrial diameter were measured from the M-mode recordings at enddiastole. LV fractional shortening was calculated. LV ejection fraction was determined using the formula of Teichholz et al. 26 From pulsed Doppler ultrasound scanning recordings of the mitral inflow velocities, the following Doppler parameters were analyzed: peak early (Em) and late (Am) transmitral filling velocities, the ratio of early to late peak velocities (Em/Am), and deceleration time of Em. 27 Pulsed wave Doppler tissue recordings were obtained from the lateral, septal, anterior, and inferior side of the mitral annulus. The means of the measurements of these sites were calculated. As was performed for RV, the LV MPI (LVMPI) was calculated as ða À bÞ=b. 14 ''a'' was equal to the sum of isovolumic contraction time (ICT) and ejection time (ET) and isovolumic relaxation time (IRT). ''b'' was measured as the duration of the systolic annular velocity (ET).
The absolute difference for the same observer was 0.0170.03, and the absolute difference between observers was 0.0270.05 for MPI. Intraobserver and interobserver variabilities (expressed as the absolute difference divided by the mean of measurements) were 1%74% and 1%75% for MPI, respectively.
Statistical analysis
Results are expressed as mean71 SD or frequency expressed as a percent. Comparisons of the results were made with the w 2 -test and the Fisher's exact test when appropriate for categorical variables and the unpaired-t test, and Mann-Whitney U-test when appropriate for continuous variables. Pearson correlation coefficient and Spearman correlation coefficient when appropriate were used to correlate the MPI with the echocardiographic and clinical indexes. Receiver-operating characteristic (ROC) curves were constructed for RVMPI and LVMPI for the differentiation of the patients with bronchiectasis from controls. A P value o0.05 was considered to be statistically significant.
Results
Study population
The clinical characteristics of the study populations are shown in Table 1 . The mean age of patients with bronchiectasis was similar to that of the control subjects. Also, no difference was noted in sex, body mass index, smoking status, and diastolic blood pressure in the patients compared with controls. Patients with bronchiectasis had a higher systolic blood pressure and heart rate than the control populations. Partial pressure of arterial oxygen, FEV 1 , and FVC of the patients was lower than normal reference values. The control group consisting of 22 healthy subjects was shown to have normal pulmonary function (FEV 1 480%, FVC480%, FEV 1 /FVC470%). None of the study population was 
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RV function
None of the patients had RV myocardial hypokinesis, or flattening or compression of the interventricular septum. RV structural and functional echocardiographic parameters are shown in Table  2 . Right atrial dimension, RV dimensions, and RV systolic and diastolic areas were not different between the groups (P40.05 for all). RV systolic function (assessed by RV fractional shortening, RV area change, and TAPSE) was also not different (P40.05 for all). Although PASP was found to tend to be higher in the patients than in the controls, the difference was not significant (P40.05), whereas ET/AT ratio of pulmonary flow was significantly different (P ¼ 0.012). There were insignificant differences between the groups in Et, Et deceleration time, and At (P40.05 for all). But the difference in Et/At reached significance (P ¼ 0.026).
From tissue Doppler systolic time intervals, both ICTr and ETr were impaired in the patients compared with controls (P ¼ 0.043 and 0.012, respectively). Also, IRTr was longer in the patient group (P ¼ 0.001). As a result of these differences, RVMPI was significantly higher in the patients (0.6670.19 and 0.4470.06, Po0.001). Comparisons of RVMPI, IRTr, ICTr, and ETr between the groups are shown in Fig. 2 .
LV function
Left atrial dimension, LV dimensions, systolic function (represented by fractional shortening and ejection fraction), and wall thickness in patients with bronchiectasis were similar to that of controls (Table 3) . LV diastolic function, represented by Em, Am, Em/Am ratio, and deceleration time of Em were all impaired in the patients group (Po0:05 for all).
Tissue Doppler-derived ICT and IRT were longer, and ET was shorter in those with bronchiectasis (P ¼ 0.001, Po0.001, and P ¼ 0.019, respectively). LVMPI was higher in the patients than in controls ARTICLE IN PRESS (0.6370.17 and 0.4170.07, Po0.001). Comparisons of LVMPI, IRT, ICT, and ET between the patients and controls are illustrated in Fig. 3 .
Correlations of the RVMPI and LVMPI with clinical and echocardiographic variables
In the patients with bronchiectasis, RVMPI was correlated with the number of involved lung lobe, partial pressure of arterial oxygen, and ET/AT ratio of pulmonary flow (Po0.05 for all correlation). LVMPI was not related to these variables. On the other hand, LVMPI was correlated only with RVMPI (r ¼ 0.724, Po0.001). Neither LVMPI nor RVMPI was correlated to age, gender, smoking status, systolic or diastolic blood pressure, heart rate, PASP, FEV 1 , FVC, FEV 1 /FVC, partial pressure of carbon dioxide, and bilateral pulmonary involvement (Table 4 ).
Sensitivity and specificity values of RVMPI and LVMPI for differentiation of bronchiectatic patients from controls
In the ROC analysis, the area under the curve was 0.929 for the RVMPI and 0.937 for the LVMPI for the differentiation of the patients with bronchiectasis from controls. An RVMPIX0.47 was associated with the most optimal sensitivity (96%) and specificity (72.7%) rates for the differentiation of the patients with bronchiectasis from controls. An RVMPIX0.47 was found in 30 subjects (63.8%), and the RVMPI was o0.47 in 17 subjects (36.2%). Of 30 subjects with RVMPIX0.47, 20 were bronchiectasis patients (80%), whereas only 1 of 17 subjects with RVMPI o0.47 were bronchiectasis patients (5.9%, Po0.001).
An RVMPIp0.45 was associated with a 100% sensitivity rate, and an RVMPIX0.55 was associated with a 100% specificity rate for the differentiation of the patients with bronchiectasis from controls. Subjects with an RVMPIX0.55 (11 subjects) were all bronchiectasis patients, and none of those with an RVMPIp0.45 (12 subjects ).
An LVMPIX0.49 was associated with the most optimal sensitivity (84.0%) and specificity (86.4%) rates for the differentiation of the patients with bronchiectasis from controls. An LVMPIX0.49 was found in 24 subjects (51.1%), and it was o0.49 in 23 subjects (48.9%). Of 24 subjects with LVMPIX0.49, 21 were bronchiectasis patients (87.5%) and only 4 of 23 subjects with LVMPIo0.49 were bronchiectasis patients (17.4%, Po0.001).
An LVMPIp0.37 was associated with 100% sensitivity rate, and an LVMPIX0.52 was associated with a 100% specificity rate for the differentiation of the patients with bronchiectasis from controls. Subjects with an LVMPIX0.52 (16 subjects) were all bronchiectasis patients, and none of those with an LVMPIp0.37 (6 subjects). 
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Discussion
This study firstly showed that adult patients with bronchiectasis demonstrate impairment of right and left cardiac function when compared to normal control subjects. We also observed that the abnormal RV function in patients with bronchiectasis was related to arterial oxygen tension, the number of involved lung lobe and AT/ET ratio of pulmonary flow. LV dysfunction in patients with bronchiectasis was independent of arterial oxygen tension, respiratory function test parameters, the parameters that reflect pulmonary arterial pressure, presence of bilateral bronchiectasis, or the number of involved lobe. RV and LV dysfunctions are related to each other. Generally, the disturbances in overall lung function are more dependent on the extent of involvement than on the anatomic type of bronchiectasis. With progressive or extensive bronchiectasis, arterial hypoxemia may develop secondary to abnormalities in gas exchange in adjacent areas. 9 A number of possible mechanisms might be considered to explain these findings. The obstructive defect of airways is present in bronchiectasis. 28 Airflow obstruction results from obliterative bronchiolitis, with or without associated airway hyper-responsiveness. 29 Our findings demonstrated impaired pulmonary functions in keeping with this knowledge. Chronic airway obstruction may lead to hypoxemia and increase in pulmonary vascular resistance.
Hypoxemia is an important factor that is known to affect RV and LV functions. 7, 8, 30 Although the role of hypoxemia and hypercapnia in the development of RV dysfunction has been well-documented in patients with CF, 7,8 this issue has not been evaluated in bronchiectatic patients so far. Both intermittent and sustained hypoxemias have been implicated in the pathogenesis of pulmonary hypertension in animal models, and in humans with COPD. 31, 32 Hypoxic pulmonary vasoconstriction would be expected to induce major RV function changes in response to increased afterload. 32 Chronic hypoxia in patients with bronchiectasis eventually may lead to increase in pulmonary vascular resistance, thereby a condition of excessive RV work. Our study showed that the levels of partial pressure of arterial oxygen were correlated with RV functions. Hypoxia should exert predominant effects on the RV because of increased loading due to hypoxia-induced pulmonary vasoconstriction. 33 On the other hand, negative inotropic effects of hypoxia may lead to decrease of both LV and RV systolic performances. 34 But arterial oxygen pressure was not related to LVMPI in our study.
In addition, pulmonary hypertension has a major effect on RV function in patients with various pulmonary diseases such as CF, 8 and COPD. [3] [4] [5] Researchers suggested the possibility of hemodynamic alterations in the lungs of patients with bronchiectasis. 35 It is known that destruction of the structural components of the bronchial wall occurs in bronchiectasis. Diffuse systemic-pulmonary anastomoses occur in granulomatous tissue within bronchiectatic segments. When such anastomoses are enlarged to a certain degree, oxygenated blood would shunt from high-pressure systemic bronchial and intercostal arteries to the low-pressure pulmonary circulation. Chronic shunt flow may lead to increase in pulmonary arterial pressure, and thereby in RV work. The association of RVMPI with involved lobe number may be due to the amount of the shunt flow. However, we were not able to assess the presence of systemic-pulmonary anastomoses. Separately, we were able to document the presence of pulmonary hypertension (PASP430 mmHg) in only one of the 25 patients studied by assessing tricuspid regurgitation. There was an insignificant difference in PASP between the patients and controls. Furthermore, PASP was not correlated with RVMPI or LVMPI.
The Doppler echocardiographic evaluation of pulmonary hypertension usually relies on the measurement of the maximal velocity of tricuspid valve regurgitant jet and the calculation of a systolic trans-tricuspid pressure gradient based on the simplified form of the Bernouilli equation. 23 The resulting systolic pulmonary artery pressure estimate is generally correlated to invasively measured pressure. Mean pulmonary artery pressure can also be estimated from the morphology of pulmonary artery blood flow, with a decreased AT/ ET in proportion to increased mean pulmonary artery pressure. 24 These measurements may be more sensitive to pulmonary-vasoconstriction-related increase in RV afterload. 24 In the current study, it is shown that there was a decreased pulmonary flow AT/ET ratio in patients with bronchiectasis, indicating pulmonary vasoconstriction and increased pulmonary vascular resistance. In addition, in contrast to PASP obtained by tricuspid regurgitation, decreased ET/AT levels were associated with RVMPI. Why PASP did not correlate to RVMPI while AT/ET did in the present study is unclear. It may be that PASP remains less sensitive than AT/ET to increase in RV afterload. LV dysfunctions in COPD or CF have been shown and related to pulmonary arterial pressure [3] [4] [5] and septal leftward shift. 4 In a new study, we have demonstrated that LV myocardial performance is also related to RV performance. 5 As seen in that study, LVMPI was related to RVMPI in the current study. The heart is composed of two muscular pumps that are connected in series to one another by the pulmonary and systemic circulations. The functional integration of these pumps is not only through their series of arrangements but also through their anatomic features and the presence of the pericardium. 36 Furthermore, RV and LV share the interventricular septum. Thus, alterations in RV size and function will influence LV performance.
The etiology of the observed RV and LV dysfunctions in patients with bronchiectasis is potentially multifold. Potential mechanisms should be assessed in the large future studies.
Although patients with bronchiectasis had normal LV and RV conventional systolic function parameters, the RVMPI and LVMPI were significantly different from control subjects' levels. The MPI has been shown to be better than conventional RV and LV systolic function parameters in predicting the prognosis and survival. [15] [16] [17] Therefore, the increased RVMPI and LVMPI, even when RV and LV conventional systolic function parameters are normal, in patients with bronchiectasis strongly suggest the presence of RV and LV dysfunctions. The elevations of the RVMPI and LVMPI in the patients were caused not only by prolongation of diastolic time intervals (IRTr and IRT) but also by differences of systolic time intervals (ICTr, ETr, ICT and ET). Therefore, it can be suggested that both systolic and diastolic dysfunctions are present in bronchiectasis.
According to ROC analysis results, RVMPI and LVMPI can reliably separate the patients with bronchiectasis from controls. There was insignificant overlapping between the groups in both parameters. Therefore, these variables can be reliably used in the management of bronchiectatic patients.
Conventional pulsed wave Doppler-derived MPI is proposed as a potentially useful predictor of systolic and diastolic cardiac functions. [15] [16] [17] However, there is an important limitation in that the interval between the end and the onset of mitral inflow, and ejection time is measured sequentially and not on the same cardiac cycle in this method. Because of this, results are probably less reliable in the presence of heart rate fluctuation even if normal in sinus rhythm is present. Pulsed wave Doppler tissue, as used in this study, can simultaneously record systolic and diastolic mitral annular velocities. Determination of MPI derived by pulsed wave Doppler tissue requires measurement of only two simple intervals on the same cardiac cycle. It is shown that MPI derived from the mitral annulus by pulsed wave Doppler tissue correlates well with MPI derived by conventional pulsed wave Doppler and can be used as a simple and reliable method for assessing LV myocardial performance even in the presence of heart rate fluctuation in patients with in sinus rhythm. 37 Therefore, we used pulsed wave Doppler tissue in obtaining the MPI.
Cardiac function has been assessed in only two previous studies in patients with bronchiectasis. In one of these, cardiac functions were assessed primarily in CF, and only 9 patients with bronchiectasis enrolled. 38 RV systolic function was found to be impaired compared to controls by radionuclide ventriculography. RV diastolic function was not assessed in that study. LV ejection fraction was similar to the controls' levels in the patients with bronchiectasis. The assessment of LV diastolic function by radionuclide ventriculography showed no difference than controls. Due to the too low patients' number, the results of this study may be less reliable. Another study that assessed ventricular function in bronchiectasis was performed in a group of children patients. 39 In that study, there was not a control group, and only LV systolic and diastolic functions were assessed by conventional methods. LV systolic function was found to be normal and diastolic function to be impaired. Interestingly, there was an inverse relation between isovolumic relaxation time and clinical score of bronchiectasis, indicating that more advanced disease is related to less impairment of LV diastolic function. It is very important to consider that, in our study, enough number of patients were enrolled to the study, they were compared with controls, and both RV and LV systolic and diastolic functions were assessed both by conventional methods and by a novel and more sensitive method.
This study demonstrated RV and LV dysfunctions in patients with bronchiectasis. However, the clinical significance of these results is not clear. Further research is needed to investigate the prognostic significance of RV and LV dysfunctions because of bronchiectasis. In this study, heart rate was different among the groups. Doppler-derived isovolumic relaxation and contraction times, and ejection time have been shown to be dependent on heart rate. 15, 36 Because of this, these intervals were adjusted for heart rate in our study. On the other hand, the MPI is not greatly influenced by changes in heart rate. 40 Also, systolic blood pressure was different between the groups. However, data regarding the impact of blood pressure on MPI were controversial. While a previous study demonstrated that the MPI is not greatly influenced by changes in blood pressure, 41 another one demonstrated that it is influenced by increasing blood pressure. 42 In our study, however, there was no association between systolic blood pressure and the MPI according to correlation test results. Therefore, it can be suggested that higher systolic blood pressure does not play a role in the difference of MPI between the groups.
In conclusion, by using pulsed wave tissue Doppler echocardiographic technique, we have demonstrated a marked LV and RV dysfunctions in patients with bronchiectasis. RV function in these patients is related to arterial oxygen tension, the number of involved lung lobe and AT/ET ratio of pulmonary flow. LV dysfunction level is associated only with RV functions.
